Symptomatic deep venous thrombosis of the lower limb
- PMID: 9821027
Symptomatic deep venous thrombosis of the lower limb
Abstract
Background: Deep vein thrombosis (DVT) is a common problem in clinical practice causing severe complications. In this retrospective study, the distribution and extent of DVT in the lower limb in symptomatic patients were evaluated. Certain risk factors were also investigated.
Methods: The venograms of 187 symptomatic individuals (postoperative, medical, and out-patient) with suspected DVT and symptoms having been present for less than 6 days, were reviewed. Seventy-seven limbs of 76 patients had DVT. Twenty-seven were male (age range 14-82 years, mean 57) and 49 female (age range 12-82, mean 56).
Results: Age over 40 years and gender (female) were significant predisposing factors, (Z = 4.23, p < 0.001 and Z = 2.19, p < 0.05 respectively). Isolated calf DVT alone was the most common pattern (46%, 36 of 77 limbs), and no difference was seen between postoperative and medical patients (chi 2-test, p = 0.7). Postoperative DVT was found in 29 (38%) limbs. Prophylaxis with LMWH had been given in only 15 of them (52%). No difference was seen in the distribution and extent of thrombosis in relation to the prophylaxis with LMWH (chi 2-test, p = 0.34).
Conclusions: Identification of the predisposing factors may enable us to distinguish patients at high risk of developing DVT. The majority of the thrombi commenced in the calf veins and thus meticulous investigation of these veins in symptomatic patients with suspected DVT is necessary.
Similar articles
-
Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.Thromb Haemost. 2001 Sep;86(3):817-21. Thromb Haemost. 2001. PMID: 11583313
-
Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.Vasc Med. 2001;6(1):23-9. Vasc Med. 2001. PMID: 11358156
-
Low molecular weight heparin for deep vein thrombosis in glioma patients.J Neurol. 2002 Oct;249(10):1409-12. doi: 10.1007/s00415-002-0855-5. J Neurol. 2002. PMID: 12382158 Clinical Trial.
-
What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?Thromb Res. 2007;119(3):265-74. doi: 10.1016/j.thromres.2006.03.010. Epub 2006 May 3. Thromb Res. 2007. PMID: 16674999 Review.
-
Risk factors for symptomatic deep-vein thrombosis in patients after total ankle replacement who received routine chemical thromboprophylaxis.J Bone Joint Surg Br. 2011 Jul;93(7):921-7. doi: 10.1302/0301-620X.93B7.26257. J Bone Joint Surg Br. 2011. PMID: 21705564 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical